Calcium in PDB 1tye: Structural Basis For Allostery in Integrins and Binding of Ligand- Mimetic Therapeutics to the Platelet Receptor For Fibrinogen

The structure of Structural Basis For Allostery in Integrins and Binding of Ligand- Mimetic Therapeutics to the Platelet Receptor For Fibrinogen, PDB code: 1tye was solved by T.Xiao, J.Takagi, B.S.Coller, J.-H.Wang, T.A.Springer, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å)	50.00 / 2.90
Space group	P 62
Cell size a, b, c (Å), α, β, γ (°)	332.093, 332.093, 88.288, 90.00, 90.00, 120.00
R / Rfree (%)	21.9 / 25.4

The structure of Structural Basis For Allostery in Integrins and Binding of Ligand- Mimetic Therapeutics to the Platelet Receptor For Fibrinogen also contains other interesting chemical elements:

Magnesium	(Mg)	3 atoms
Arsenic	(As)	3 atoms

Pages:

>>> Page 1 <<< Page 2, Binding sites: 11 - 18;

Binding sites:

The binding sites of Calcium atom in the Structural Basis For Allostery in Integrins and Binding of Ligand- Mimetic Therapeutics to the Platelet Receptor For Fibrinogen (pdb code 1tye). This binding sites where shown within 5.0 Angstroms radius around Calcium atom.
In total 18 binding sites of Calcium where determined in the Structural Basis For Allostery in Integrins and Binding of Ligand- Mimetic Therapeutics to the Platelet Receptor For Fibrinogen, PDB code: 1tye:
Jump to Calcium binding site number: 1; 2; 3; 4; 5; 6; 7; 8; 9; 10;

Calcium binding site 1 out of 18 in the Structural Basis For Allostery in Integrins and Binding of Ligand- Mimetic Therapeutics to the Platelet Receptor For Fibrinogen


Mono view


Stereo pair view

A full contact list of Calcium with other atoms in the Ca binding site number 1 of Structural Basis For Allostery in Integrins and Binding of Ligand- Mimetic Therapeutics to the Platelet Receptor For Fibrinogen within 5.0Å range: probe atom residue distance (Å) B Occ A:Ca1404 b:61.7 occ:1.00 O A:THR250 2.0 72.0 1.0 O A:ASP247 2.1 83.2 1.0 OE2 A:GLU252 2.3 62.1 1.0 OD1 A:ASP245 2.3 67.9 1.0 OE2 A:GLU243 2.5 62.6 1.0 OG1 A:THR250 2.6 67.8 1.0 OE1 A:GLU243 2.6 62.6 1.0 CD A:GLU243 2.9 62.2 1.0 C A:THR250 3.0 71.9 1.0 CD A:GLU252 3.1 62.4 1.0 C A:ASP247 3.2 83.1 1.0 OE1 A:GLU252 3.2 62.8 1.0 CG A:ASP245 3.3 68.9 1.0 CA A:THR250 3.6 72.8 1.0 CB A:THR250 3.6 71.7 1.0 OD2 A:ASP245 3.7 70.2 1.0 N A:THR250 3.8 77.2 1.0 CA A:ASP247 3.9 82.2 1.0 N A:ASP247 4.0 80.8 1.0 N A:THR251 4.0 69.9 1.0 CB A:ASP247 4.0 82.7 1.0 N A:LEU248 4.2 83.8 1.0 CA A:THR251 4.4 66.9 1.0 CG A:GLU243 4.4 60.4 1.0 N A:ASP245 4.5 66.0 1.0 CG A:GLU252 4.5 61.0 1.0 CA A:LEU248 4.5 84.0 1.0 CB A:ASP245 4.6 68.8 1.0 C A:THR251 4.7 64.4 1.0 CG A:ASP247 4.8 84.3 1.0 N A:GLY246 4.8 75.2 1.0 C A:LEU248 4.8 83.2 1.0 N A:PHE244 4.8 59.5 1.0 CG2 A:THR250 4.8 69.9 1.0 C A:GLY246 4.9 79.9 1.0 N A:ASN249 4.9 82.4 1.0 CA A:GLU243 4.9 58.4 1.0 CA A:ASP245 4.9 69.5 1.0 C A:ASP245 5.0 72.6 1.0 N A:GLU252 5.0 60.4 1.0

Calcium binding site 2 out of 18 in the Structural Basis For Allostery in Integrins and Binding of Ligand- Mimetic Therapeutics to the Platelet Receptor For Fibrinogen


Mono view


Stereo pair view

A full contact list of Calcium with other atoms in the Ca binding site number 2 of Structural Basis For Allostery in Integrins and Binding of Ligand- Mimetic Therapeutics to the Platelet Receptor For Fibrinogen within 5.0Å range: probe atom residue distance (Å) B Occ A:Ca1405 b:75.4 occ:1.00 OD1 A:ASP301 2.4 74.6 1.0 OD2 A:ASP305 2.4 64.1 1.0 OD1 A:ASP297 2.4 66.8 1.0 O A:ARG303 2.4 69.6 1.0 OD1 A:ASP305 2.5 65.5 1.0 OD1 A:ASN299 2.7 53.6 1.0 CG A:ASP305 2.7 65.1 1.0 CG A:ASP301 3.1 71.9 1.0 OD2 A:ASP301 3.2 72.6 1.0 CG A:ASP297 3.3 66.2 1.0 CG A:ASN299 3.6 54.8 1.0 C A:ARG303 3.6 69.1 1.0 ND2 A:ASN299 3.9 54.0 1.0 NH2 A:ARG335 3.9 98.0 1.0 OD2 A:ASP297 4.0 63.8 1.0 CA A:ASP297 4.2 63.2 1.0 CB A:ASP305 4.2 63.8 1.0 CB A:ASP297 4.3 64.4 1.0 N A:ARG303 4.3 69.7 1.0 CA A:ARG303 4.3 70.7 1.0 N A:ASP305 4.4 61.1 1.0 CB A:ARG303 4.5 73.2 1.0 N A:ASN299 4.5 58.9 1.0 C A:HIS304 4.5 61.9 1.0 CB A:ASP301 4.5 67.7 1.0 N A:VAL298 4.5 60.6 1.0 N A:ASP301 4.6 61.7 1.0 N A:HIS304 4.6 66.6 1.0 C A:ASP297 4.6 62.4 1.0 CA A:ASP305 4.8 61.7 1.0 O A:HIS304 4.8 60.7 1.0 N A:GLN333 4.8 62.6 1.0 CB A:ASN299 4.8 55.7 1.0 CA A:HIS304 4.9 63.5 1.0 CA A:ASP301 4.9 64.0 1.0 CD2 A:LEU332 5.0 59.0 1.0

Calcium binding site 3 out of 18 in the Structural Basis For Allostery in Integrins and Binding of Ligand- Mimetic Therapeutics to the Platelet Receptor For Fibrinogen


Mono view


Stereo pair view

A full contact list of Calcium with other atoms in the Ca binding site number 3 of Structural Basis For Allostery in Integrins and Binding of Ligand- Mimetic Therapeutics to the Platelet Receptor For Fibrinogen within 5.0Å range: probe atom residue distance (Å) B Occ A:Ca1406 b:73.5 occ:1.00 OD1 A:ASP365 2.1 74.9 1.0 OD1 A:ASP367 2.1 78.8 1.0 O A:TYR371 2.1 68.8 1.0 OD1 A:ASP373 2.6 70.8 1.0 OD1 A:ASP369 2.7 77.1 1.0 OD2 A:ASP373 2.8 68.8 1.0 CG A:ASP373 3.0 67.0 1.0 CG A:ASP367 3.2 78.7 1.0 CG A:ASP365 3.3 75.0 1.0 C A:TYR371 3.3 69.0 1.0 CG A:ASP369 3.8 76.3 1.0 OD2 A:ASP367 3.8 79.0 1.0 CA A:ASP365 3.9 72.1 1.0 N A:ASP367 4.0 75.7 1.0 N A:LEU366 4.0 70.4 1.0 N A:TYR371 4.0 71.5 1.0 C A:ASP365 4.0 71.3 1.0 CA A:TYR371 4.1 70.7 1.0 OD2 A:ASP365 4.1 75.3 1.0 CB A:ASP365 4.2 73.7 1.0 N A:ARG368 4.2 77.0 1.0 N A:ASP369 4.3 76.8 1.0 N A:ASN372 4.3 65.8 1.0 CB A:TYR371 4.3 73.6 1.0 OD2 A:ASP369 4.4 74.7 1.0 C A:ASN372 4.5 59.9 1.0 CB A:ASP367 4.5 77.6 1.0 CA A:ASN372 4.5 60.8 1.0 N A:ASP373 4.5 59.5 1.0 CB A:ASP373 4.5 63.0 1.0 CA A:ASP367 4.5 76.6 1.0 C A:ASP367 4.7 76.8 1.0 CA A:LEU366 4.8 71.0 1.0 C A:LEU366 4.8 73.6 1.0 CB A:ASP369 4.8 76.2 1.0 N A:GLY394 4.8 68.4 1.0 O A:ASP365 4.8 71.1 1.0 N A:GLY370 4.9 74.1 1.0 O A:ASN372 4.9 59.2 1.0 CA A:ASP369 4.9 75.8 1.0

Calcium binding site 4 out of 18 in the Structural Basis For Allostery in Integrins and Binding of Ligand- Mimetic Therapeutics to the Platelet Receptor For Fibrinogen


Mono view


Stereo pair view

A full contact list of Calcium with other atoms in the Ca binding site number 4 of Structural Basis For Allostery in Integrins and Binding of Ligand- Mimetic Therapeutics to the Platelet Receptor For Fibrinogen within 5.0Å range: probe atom residue distance (Å) B Occ A:Ca1407 b:68.9 occ:1.00 O A:TYR432 2.1 84.3 1.0 OD1 A:ASP428 2.2 82.6 1.0 OD1 A:ASN430 2.3 92.6 1.0 OD2 A:ASP434 2.6 81.4 1.0 OD1 A:ASP426 2.7 68.8 1.0 OD1 A:ASP434 2.7 81.7 1.0 CG A:ASP434 3.0 80.9 1.0 CG A:ASP428 3.0 83.2 1.0 OD2 A:ASP428 3.1 83.1 1.0 C A:TYR432 3.2 84.7 1.0 CG A:ASN430 3.3 89.5 1.0 ND2 A:ASN430 3.8 89.4 1.0 CG A:ASP426 3.9 71.1 1.0 CA A:TYR432 3.9 85.8 1.0 N A:TYR432 4.0 85.9 1.0 CB A:TYR432 4.0 87.5 1.0 O A:ALA450 4.1 98.0 1.0 N A:ASN430 4.2 86.6 1.0 CB A:ALA450 4.3 91.7 1.0 N A:PRO433 4.3 83.7 1.0 CA A:ASP426 4.3 69.5 1.0 N A:ASP428 4.4 80.6 1.0 C A:PRO433 4.4 79.7 1.0 CB A:ASP428 4.4 81.8 1.0 CB A:ASN430 4.4 87.6 1.0 N A:ALA450 4.4 86.9 1.0 CB A:ASP434 4.4 78.3 1.0 N A:ILE427 4.4 72.2 1.0 N A:ASP434 4.6 78.4 1.0 O A:PRO433 4.6 79.6 1.0 N A:ASP429 4.6 85.6 1.0 CB A:ASP426 4.7 70.4 1.0 CA A:PRO433 4.7 81.8 1.0 C A:ASP426 4.7 70.7 1.0 CA A:ASN430 4.7 86.4 1.0 OD2 A:ASP426 4.8 70.4 1.0 CA A:ALA450 4.8 92.7 1.0 C A:ALA450 4.8 96.9 1.0 CA A:ASP428 4.8 82.1 1.0 C A:ASN430 4.9 86.4 1.0 CA A:ASP434 5.0 76.2 1.0

Calcium binding site 5 out of 18 in the Structural Basis For Allostery in Integrins and Binding of Ligand- Mimetic Therapeutics to the Platelet Receptor For Fibrinogen


Mono view


Stereo pair view

A full contact list of Calcium with other atoms in the Ca binding site number 5 of Structural Basis For Allostery in Integrins and Binding of Ligand- Mimetic Therapeutics to the Platelet Receptor For Fibrinogen within 5.0Å range: probe atom residue distance (Å) B Occ B:Ca1402 b:49.0 occ:1.00 OD1 B:ASP127 2.2 44.8 1.0 O B:HOH1406 2.3 29.0 1.0 O B:SER123 2.4 36.4 1.0 OD2 B:ASP251 2.7 41.3 1.0 OD1 B:ASP126 2.7 66.4 1.0 OD2 B:ASP126 3.1 68.0 1.0 CG B:ASP127 3.1 46.9 1.0 CG B:ASP126 3.2 66.0 1.0 OD2 B:ASP127 3.3 46.5 1.0 CG B:ASP251 3.5 39.5 1.0 C B:SER123 3.6 39.4 1.0 CB B:ASP251 3.9 39.7 1.0 OD1 B:ASP251 4.4 39.2 1.0 N B:MET124 4.5 41.8 1.0 CB B:ASP127 4.5 47.5 1.0 CA B:MET124 4.5 46.5 1.0 CA B:SER123 4.5 39.6 1.0 CB B:SER123 4.6 39.4 1.0 CB B:ASP126 4.7 60.1 1.0 N B:ASP127 4.7 50.5 1.0 C B:MET124 4.9 48.6 1.0 N B:ASP126 5.0 54.1 1.0

Calcium binding site 6 out of 18 in the Structural Basis For Allostery in Integrins and Binding of Ligand- Mimetic Therapeutics to the Platelet Receptor For Fibrinogen


Mono view


Stereo pair view

A full contact list of Calcium with other atoms in the Ca binding site number 6 of Structural Basis For Allostery in Integrins and Binding of Ligand- Mimetic Therapeutics to the Platelet Receptor For Fibrinogen within 5.0Å range: probe atom residue distance (Å) B Occ B:Ca1403 b:28.1 occ:1.00 OD1 B:ASN215 1.9 42.0 1.0 O B:PRO219 2.0 35.8 1.0 OD2 B:ASP158 2.0 26.1 1.0 OD1 B:ASP217 2.2 41.1 1.0 O B:ASP217 2.2 31.5 1.0 OE2 B:GLU220 2.3 37.0 1.0 CG B:ASN215 3.1 39.1 1.0 CG B:ASP217 3.1 40.4 1.0 C B:PRO219 3.2 35.0 1.0 CG B:ASP158 3.2 32.9 1.0 C B:ASP217 3.3 33.6 1.0 CD B:GLU220 3.4 36.7 1.0 CA B:GLU220 3.7 37.5 1.0 ND2 B:ASN215 3.8 42.9 1.0 OD2 B:ASP217 3.8 40.7 1.0 N B:GLU220 3.9 34.4 1.0 CB B:ASP158 3.9 33.8 1.0 CA B:ASP217 4.0 33.5 1.0 C1 B:CAC1301 4.0 0.8 1.0 OE1 B:GLU220 4.0 36.1 1.0 N B:ASP217 4.1 32.7 1.0 C B:ALA218 4.1 36.3 1.0 CB B:ASP217 4.1 36.5 1.0 N B:PRO219 4.2 36.0 1.0 O B:ALA218 4.2 39.6 1.0 OD1 B:ASP158 4.2 31.7 1.0 NE2 B:HIS255 4.2 42.3 1.0 CB B:ASN215 4.3 35.9 1.0 CA B:PRO219 4.3 35.7 1.0 CG B:GLU220 4.3 36.8 1.0 CB B:GLU220 4.4 37.2 1.0 N B:ALA218 4.4 34.1 1.0 CD2 B:HIS255 4.5 41.7 1.0 CA B:ALA218 4.7 34.7 1.0 CD B:PRO219 4.8 34.0 1.0 O B:VAL157 4.9 38.8 1.0 C B:GLU220 4.9 38.7 1.0

Calcium binding site 7 out of 18 in the Structural Basis For Allostery in Integrins and Binding of Ligand- Mimetic Therapeutics to the Platelet Receptor For Fibrinogen


Mono view


Stereo pair view

A full contact list of Calcium with other atoms in the Ca binding site number 7 of Structural Basis For Allostery in Integrins and Binding of Ligand- Mimetic Therapeutics to the Platelet Receptor For Fibrinogen within 5.0Å range: probe atom residue distance (Å) B Occ C:Ca1411 b:58.7 occ:1.00 OD1 C:ASP245 2.1 70.0 1.0 O C:ASP247 2.1 72.3 1.0 OE2 C:GLU243 2.2 53.0 1.0 OE2 C:GLU252 2.2 54.9 1.0 O C:THR250 2.5 62.5 1.0 OG1 C:THR250 2.7 62.3 1.0 OE1 C:GLU243 2.7 52.1 1.0 CD C:GLU243 2.8 52.7 1.0 CD C:GLU252 3.1 54.1 1.0 CG C:ASP245 3.2 68.7 1.0 C C:ASP247 3.3 72.4 1.0 C C:THR250 3.3 62.2 1.0 OE1 C:GLU252 3.4 54.0 1.0 OD2 C:ASP245 3.7 69.1 1.0 CB C:THR250 3.8 62.4 1.0 CA C:THR250 3.9 63.2 1.0 N C:ASP247 4.0 73.1 1.0 CA C:ASP247 4.0 72.7 1.0 N C:THR250 4.1 65.9 1.0 N C:ASP245 4.1 61.8 1.0 CB C:ASP247 4.2 73.6 1.0 CG C:GLU243 4.3 51.8 1.0 N C:LEU248 4.3 72.1 1.0 N C:THR251 4.3 60.8 1.0 CB C:ASP245 4.4 66.4 1.0 CG C:GLU252 4.5 52.4 1.0 CA C:LEU248 4.5 72.5 1.0 CA C:ASP245 4.5 65.3 1.0 N C:GLY246 4.5 68.7 1.0 C C:ASP245 4.5 67.0 1.0 N C:PHE244 4.6 52.5 1.0 C C:GLY246 4.6 72.8 1.0 CA C:THR251 4.6 59.0 1.0 CA C:GLU243 4.8 51.5 1.0 C C:LEU248 4.8 71.2 1.0 C C:THR251 5.0 56.1 1.0

Calcium binding site 8 out of 18 in the Structural Basis For Allostery in Integrins and Binding of Ligand- Mimetic Therapeutics to the Platelet Receptor For Fibrinogen


Mono view


Stereo pair view

A full contact list of Calcium with other atoms in the Ca binding site number 8 of Structural Basis For Allostery in Integrins and Binding of Ligand- Mimetic Therapeutics to the Platelet Receptor For Fibrinogen within 5.0Å range: probe atom residue distance (Å) B Occ C:Ca1412 b:46.3 occ:1.00 OD1 C:ASP301 2.2 73.1 1.0 OD1 C:ASN299 2.2 65.6 1.0 OD2 C:ASP305 2.2 47.9 1.0 OD1 C:ASP297 2.4 64.5 1.0 O C:ARG303 2.4 63.4 1.0 OD1 C:ASP305 2.4 49.2 1.0 CG C:ASP305 2.6 51.0 1.0 CG C:ASP301 3.0 72.5 1.0 OD2 C:ASP301 3.1 74.6 1.0 CG C:ASN299 3.2 64.3 1.0 C C:ARG303 3.4 63.2 1.0 CG C:ASP297 3.4 65.7 1.0 ND2 C:ASN299 3.5 63.0 1.0 CB C:ARG303 3.8 65.7 1.0 CA C:ARG303 3.9 64.5 1.0 N C:ARG303 4.0 66.1 1.0 CB C:ASP305 4.1 51.5 1.0 OD2 C:ASP297 4.2 66.6 1.0 CB C:ASP297 4.2 63.9 1.0 CA C:ASP297 4.2 63.3 1.0 C C:HIS304 4.3 56.4 1.0 N C:ASN299 4.4 62.7 1.0 N C:ASP305 4.4 54.0 1.0 CB C:ASP301 4.4 70.5 1.0 N C:HIS304 4.4 61.2 1.0 O C:GLN333 4.5 63.7 1.0 N C:VAL298 4.5 63.2 1.0 O C:HIS304 4.5 55.8 1.0 CB C:ASN299 4.5 63.7 1.0 N C:ASP301 4.6 67.4 1.0 CA C:ASP305 4.7 52.8 1.0 C C:ASP297 4.7 63.6 1.0 CA C:HIS304 4.8 58.4 1.0 N C:GLN333 4.8 60.1 1.0 CA C:ASN299 4.9 64.6 1.0 N C:GLY302 4.9 68.5 1.0 CA C:ASP301 4.9 68.7 1.0 CD2 C:LEU332 4.9 52.3 1.0

Calcium binding site 9 out of 18 in the Structural Basis For Allostery in Integrins and Binding of Ligand- Mimetic Therapeutics to the Platelet Receptor For Fibrinogen


Mono view


Stereo pair view

A full contact list of Calcium with other atoms in the Ca binding site number 9 of Structural Basis For Allostery in Integrins and Binding of Ligand- Mimetic Therapeutics to the Platelet Receptor For Fibrinogen within 5.0Å range: probe atom residue distance (Å) B Occ C:Ca1413 b:70.0 occ:1.00 O C:TYR371 2.1 69.2 1.0 OD1 C:ASP367 2.2 85.1 1.0 OD1 C:ASP365 2.3 82.2 1.0 OD1 C:ASP373 2.6 67.2 1.0 OD2 C:ASP373 2.6 66.2 1.0 OD1 C:ASP369 2.7 89.2 1.0 CG C:ASP373 2.9 65.8 1.0 CG C:ASP365 3.3 80.3 1.0 C C:TYR371 3.3 70.0 1.0 CG C:ASP367 3.4 84.4 1.0 CG C:ASP369 3.8 87.6 1.0 OD2 C:ASP367 3.9 83.5 1.0 OD2 C:ASP365 4.0 78.7 1.0 CA C:ASP365 4.0 78.3 1.0 N C:ASP367 4.0 83.7 1.0 N C:TYR371 4.1 73.5 1.0 N C:LEU366 4.1 80.4 1.0 CA C:TYR371 4.1 71.1 1.0 CB C:ASP365 4.2 79.2 1.0 N C:ASN372 4.3 68.4 1.0 C C:ASP365 4.3 79.1 1.0 CB C:TYR371 4.3 71.9 1.0 N C:ASP373 4.3 63.1 1.0 C C:ASN372 4.4 65.1 1.0 CB C:ASP373 4.4 63.9 1.0 CA C:ASN372 4.4 66.5 1.0 N C:ASP369 4.4 81.8 1.0 OD2 C:ASP369 4.5 88.4 1.0 N C:ARG368 4.5 82.6 1.0 CB C:ASP367 4.6 84.1 1.0 N C:GLY394 4.6 62.8 1.0 CA C:ASP367 4.6 83.7 1.0 C C:ASP367 4.8 83.0 1.0 O C:ASN372 4.9 65.5 1.0 CB C:ASP369 4.9 84.5 1.0 CA C:ASP373 4.9 61.8 1.0 N C:GLY370 5.0 79.3 1.0 C C:LEU366 5.0 83.1 1.0 CA C:LEU366 5.0 81.7 1.0

Calcium binding site 10 out of 18 in the Structural Basis For Allostery in Integrins and Binding of Ligand- Mimetic Therapeutics to the Platelet Receptor For Fibrinogen


Mono view


Stereo pair view

A full contact list of Calcium with other atoms in the Ca binding site number 10 of Structural Basis For Allostery in Integrins and Binding of Ligand- Mimetic Therapeutics to the Platelet Receptor For Fibrinogen within 5.0Å range: probe atom residue distance (Å) B Occ C:Ca1414 b:68.4 occ:1.00 O C:TYR432 2.0 81.8 1.0 OD1 C:ASP428 2.2 70.4 1.0 OD1 C:ASN430 2.3 86.5 1.0 OD1 C:ASP426 2.5 71.5 1.0 OD2 C:ASP434 2.7 72.7 1.0 OD1 C:ASP434 2.7 73.4 1.0 CG C:ASP434 3.0 71.9 1.0 C C:TYR432 3.2 82.1 1.0 CG C:ASP428 3.2 72.5 1.0 CG C:ASN430 3.3 84.0 1.0 CG C:ASP426 3.5 71.4 1.0 OD2 C:ASP428 3.6 72.7 1.0 ND2 C:ASN430 3.8 83.7 1.0 CA C:TYR432 3.9 84.4 1.0 CB C:TYR432 3.9 88.1 1.0 N C:TYR432 4.0 84.5 1.0 N C:PRO433 4.2 79.5 1.0 OD2 C:ASP426 4.2 71.4 1.0 CA C:ASP426 4.2 65.9 1.0 C C:PRO433 4.3 74.2 1.0 O C:PRO433 4.4 74.5 1.0 N C:ASP428 4.4 73.5 1.0 CB C:ASP426 4.4 69.6 1.0 CB C:ASP434 4.4 70.2 1.0 N C:ILE427 4.5 66.9 1.0 N C:ASN430 4.5 81.8 1.0 N C:ASP434 4.5 71.3 1.0 CA C:PRO433 4.5 76.8 1.0 CB C:ASP428 4.5 73.0 1.0 CB C:ASN430 4.6 82.5 1.0 N C:ASP429 4.6 79.6 1.0 CB C:ALA450 4.7 89.2 1.0 C C:ASP426 4.7 66.3 1.0 N C:ALA450 4.8 85.0 1.0 CA C:ASP428 4.9 75.1 1.0 CA C:ASN430 4.9 82.0 1.0 CA C:ASP434 5.0 68.6 1.0

T.Xiao, J.Takagi, B.S.Coller, J.-H.Wang, T.A.Springer. Structural Basis For Allostery in Integrins and Binding to Fibrinogen-Mimetic Therapeutics Nature V. 432 59 2004.
ISSN: ISSN 0028-0836
PubMed: 15378069
DOI: 10.1038/NATURE02976